Australia markets closed

Universal Biosensors, Inc. (UBI.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.90000.0000 (0.00%)
At close: 3:53PM AEDT

Universal Biosensors, Inc.

1 Corporate Avenue
Rowville, VIC 3178
Australia
61 3 9213 9000
http://www.universalbiosensors.com

Sector(s):Β Healthcare
Industry:Β Medical Devices
Full-time employees:Β 60

Key executives

NameTitlePayExercisedYear born
Mr. John Stewart Sharman M.App.Fin, CA, B EcChief Exec. Officer507.22kN/A1966
Mr. Salesh Balak BA, CACFO & Company Sec.571.19kN/A1969
Mr. Nicholas BliesnerHead of OperationsN/AN/AN/A
Ms. Ann ChewHead of HR & Internal AuditN/AN/AN/A
Dr. Ronald Chatelier BSc. (Hons.), Ph.D.Chief Research ScientistN/AN/A1960
Mr. Luke CossinsHead of R&DN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It offers SENTIA Wine Analyzer to test Free Sulphur Dioxide; prothrombin time international normalized ratio coagulation test strips; Sentia Free Sulphite test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.

Corporate governance

Universal Biosensors, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.